{
    "code": "06018651",
    "url": "https:\/\/info.fda.gov.tw\/MLMS\/H0001D.aspx?Type=Lic&LicId=06018651",
    "time": "2022-08-06 07:57:02",
    "許可證字號": "衛署醫器輸字第018651號",
    "註銷狀態": "",
    "註銷日期": "",
    "註銷理由": "",
    "製造許可登錄編號": "QSD5661",
    "有效日期": "116\/10\/26",
    "發證日期": "96\/10\/26",
    "許可證種類": "醫　器",
    "舊證字號": "",
    "醫療器材級數": "第二等級",
    "第一等級醫療器材原登錄字號": "",
    "第一等級醫療器材新登錄字號": "",
    "通關簽審文件編號": "DHA00601865108",
    "中文品名": "亞培設計師巨細胞病毒IgG抗體檢驗試劑組",
    "英文品名": "ABBOTT ARCHITECT CMV IgG",
    "效能": "ARCHITECT CMV IgG分析是一種化學冷光微粒免疫分析法(Chemiluminescent Microparticle Immunoassay;CMIA)，可用於定性測試及半定量測定人類血清及血漿中對抗巨細胞病毒(Cytomegalovirus)之IgG抗體。",
    "醫器規格": "規格及標籤、說明書或包裝變更為：詳如中文標籤、說明書或包裝核定本(原102年4月22日標籤仿單核定本正本收回作廢)。",
    "劑型": "",
    "包裝": "",
    "儲存溫度": "",
    "有效期間": "",
    "指示藥品審查基準": "",
    "標籤、仿單及包裝加註": "",
    "醫器主類別一": "C免疫學及微生物學裝置",
    "醫器次類別一": "C3175巨細胞病毒血清試劑",
    "醫器主類別二": "",
    "醫器次類別二": "",
    "醫器主類別三": "",
    "醫器次類別三": "",
    "藥品分類": "",
    "監視期限": "",
    "主成分略述": "",
    "限制項目": "02輸　入",
    "申請商名稱": "0932301100  美商亞培股份有限公司台灣分公司",
    "申請商地址": "台北市中山區民生東路三段49號5樓、6樓及51號6樓",
    "主製造廠": [
        {
            "製造廠名稱": "MIE0049000  ABBOTT IRELAND DIAGNOSTICS DIVISION",
            "製造廠廠址": "FINISKLIN BUSINESS PARK SLIGO, IRELAND",
            "製造廠公司地址": "",
            "製造廠國別": "IRELAND",
            "製程": ""
        }
    ],
    "藥理治療分類": "",
    "ingredients": [],
    "仿單外盒": [
        {
            "title": "060186510032-110-07-20.pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=06018651&Seq=033&Type=9"
        },
        {
            "title": "060186510005-110-07-20.pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=06018651&Seq=005&Type=8"
        }
    ]
}